Search

Search Constraints

You searched for: Author/Creator Mann, Helen

Search Results

3. Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer. Issue 12 (20th April 2022)

4. Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy. Issue 9 (30th October 2018)

5. Modulation of Fexofenadine Pharmacokinetics by Osimertinib in Patients With Advanced EGFR‐Mutated Non–Small Cell Lung Cancer. (15th March 2019)

6. NEPTUNE China cohort: First-line durvalumab plus tremelimumab in Chinese patients with metastatic non-small-cell lung cancer. (April 2023)

7. Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study. Issue 12 (December 2016)

8. Osimertinib in patients with T790M mutation‐positive, advanced non–small cell lung cancer: Long‐term follow‐up from a pooled analysis of 2 phase 2 studies. Issue 6 (4th December 2018)

9. Outcome of Expedited Rotator Cuff Surgery in Injured Workers: Determinants of Successful Recovery. Issue 5 (19th May 2017)